Clinical Trials Logo

Cholecystitis clinical trials

View clinical trials related to Cholecystitis.

Filter by:

NCT ID: NCT03767881 Completed - Clinical trials for Cholecystitis, Acute

AXIOS™ for Gallbladder Drainage as an Alternative to Percutaneous Drainage IDE

Start date: September 10, 2019
Phase: N/A
Study type: Interventional

To evaluate the safety and effectiveness of the AXIOS™ Stent with Electrocautery Enhanced Delivery System in the management of symptoms of acute cholecystitis as an alternative to percutaneous gallbladder drainage.

NCT ID: NCT03754751 Completed - Acute Cholecystitis Clinical Trials

Enhanced Recovery in Laparoscopic Cholecystectomy

ERLAC
Start date: January 31, 2017
Phase: N/A
Study type: Interventional

The study assesses the impact of the modified enhanced recovery protocol on the results of surgical treatment of patients with acute cholecystitis.

NCT ID: NCT03729882 Completed - Acute Cholecystitis Clinical Trials

Primary EUS-GBD in Patients With Unresectable Malignant Biliary Obstruction and Cystic Duct Orifice Involvement.

Start date: July 1, 2018
Phase: N/A
Study type: Interventional

to determine if primary prophylaxis with Endoscopic Ultrasound-Gallbladder Drainage (EUS-GBD) in unresectable cancer patients with the orifice of the cystic duct (OCD) involvement is superior to conservative management (Non EUS-guided gallbladder drainage).

NCT ID: NCT03709030 Completed - Clinical trials for Cholecystitis; Acute, Choledocholithiasis

Early MRI in Acute GallstonE Disease

E-MAGED
Start date: July 17, 2019
Phase: N/A
Study type: Interventional

This pilot study aims to determine the utility of direct Magnetic Resonance Cholangiopancreatography (MRCP) in the assessment of suspected acute gallstone disease presentations. This will take the form of a randomized controlled trial, the design of which is based on recent internal audit data which indicated that a high proportion of patients ultimately require MRCP prior to diagnosis, treatment and discharge, and suggested that early scan may improve overall costs and outcomes. Patients with symptoms and signs suggestive of suspected gallstone disease and deranged liver function tests/amylase (i.e. suggestive of a potentially obstructive gallstone disease), will be enrolled across the full range of 'front-door' locations for surgical presentations within the hospital (Emergency Department, Surgical Emergency Unit, Ambulatory Assessment Unit), and randomized to one of two diagnostic pathways which are both existing variations in current clinical care: 1. MRCP is used as the first mode of imaging; 2. following a standard care model (ultrasound then MRCP if deemed appropriate). An assessment will then be undertaken of the cost-effectiveness of early MRCP versus standard care, using the primary outcome measure of cost to diagnostic scan report calculated using hospital episode statistics (HES), with secondary outcome measures to assess the overall utility which include length of stay, time to diagnosis, overall cost of admission using HES, in-hospital complications, Patient Reported Outcome Measures (PROMs), readmission and re-attendance rates (ED/GP), and service/radiology costs.

NCT ID: NCT03708874 Completed - Shoulder Pain Clinical Trials

Pain Management of Emergency Laparoscopic Cholecystectomy in Patients With Acute Cholecystitis

Start date: October 9, 2018
Phase:
Study type: Observational [Patient Registry]

Patients diagnosed with acute cholecystitis benefit from emergency laparoscopic cholecystectomy (LC). Patients who had emergency LC showed improvement in quality of life in one month compared to those treated. Delayed LC (after the acute cholecystitis has passed) and less time to recover from work. This strategy reduces the risk of repeated referrals with more pain or pancreatitis. There are many studies on the efficacy of intraoperative intraperitoneal bupivacaine(IPBV) with elective LC on pain of IPBV. However, the prospective study of reducing the postoperative pain of emergency LC - IPBV is very few. This study will be conducted to evaluate the efficacy of IPBV in patients with emergency LC.

NCT ID: NCT03701464 Completed - Success Rate Clinical Trials

Comparison of ENGBD and PTGBD in Acute Suppurative Cholecystitis

Start date: October 10, 2018
Phase: N/A
Study type: Interventional

Comparison of ENGBD and PTGBD methods on clinical outcomes and the difficulty of cholecystectomy in later stage in patients with acute suppurative cholecystitis.

NCT ID: NCT03696823 Not yet recruiting - Clinical trials for Chronic Calculous Cholecystitis

Critical View of Safety in Laparoscopic Cholecystectomy

Start date: October 1, 2018
Phase: N/A
Study type: Interventional

This prospective cohort study aims to assess feasibility and safety of the approach of critical view of safety during laparoscopic cholecystectomy

NCT ID: NCT03643718 Recruiting - Trauma Clinical Trials

Web-based International Register of Emergency Surgery and Trauma

WIRES-T
Start date: July 2020
Phase:
Study type: Observational [Patient Registry]

The WIRES-T project (Web-based International Registry of Emergency General Surgery and Trauma) has been set up to allow to all the EGS (Emergency General Surgery) and Trauma surgeons to register their activity and to obtain a worldwide register of traumatic and non traumatic surgical emergencies. This will give the opportunity to evaluate results on a macro-data basis and to give index allowing stratifying, evaluating and improving the outcomes.

NCT ID: NCT03636841 Not yet recruiting - Cholecystitis Clinical Trials

Reduction of Operating Time by a Smoke Electroprecipitation Device for Acute Cholecystitis

Ultravision
Start date: September 2018
Phase: N/A
Study type: Interventional

The smoke produced by the electric section of the tissues during laparoscopy alters the vision of the operative field and presents potential risks. A new medical device with CE marking (Ultravision ©) has been developed to limit electroprecipitation on the wall and tissues of the abdomen. The aim of the work is to evaluate the effectiveness of this medical device in laparoscopic cholecystectomy for cholecystitis. It is an intervention for a common pathology where smoke is particularly important due to the tissue inflammation and due to the extensive dissection necessary to perform the surgical procedure. A randomized double-blinded study will be conducted in two academic hospitals (Marseille North Hospital and Timone, APHM) evaluating the use of a smoke electroprecipitation device (Ultravision ©) during laparoscopic cholecystectomy for cholecystitis operated at the acute phase. A group of 30 patients using the device will be compared to a control group of 30 patients. The evaluation will last thirty days per patient and the duration of inclusion is 2 years. The main objective is to demonstrate a significant reduction in operating duration by using the device. The secondary objectives are to reduce the CO2 consumption, the surgical incidents and the discomfort of the surgeon related to the smoke.

NCT ID: NCT03610308 Completed - Clinical trials for Cholecystitis; Gangrenous

ESTES Snapshot Audit 2018

Start date: October 1, 2018
Phase:
Study type: Observational [Patient Registry]

To explore differences in patients, techniques and outcomes across the international cohort to identify areas of practice variability in the presentation and management of acute complicated calculous biliary disease.